End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
556.3 ZAR | -0.48% | +0.95% | +2.73% |
05-01 | British American Tobacco makes GBP173 million in buybacks | AN |
04-30 | British American Tobacco Prices Debt Tender Offers | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.21 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.73% | 67.61B | - | ||
+3.40% | 19.95B | A- | ||
+7.69% | 5.5B | B- | ||
+61.02% | 2.11B | - | C+ | |
+1.02% | 1.76B | - | ||
-3.90% | 1.71B | - | D+ | |
-19.76% | 1.33B | - | B+ | |
0.00% | 656M | - | - | |
+29.48% | 601M | C+ | ||
-15.61% | 454M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- BTI Stock
- Ratings British American Tobacco p.l.c.